药品名称GLUCOPHAGE XR
申请号021202产品号001
活性成分METFORMIN HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格500MG
治疗等效代码AB1参比药物
批准日期2000/10/13申请机构BRISTOL MYERS SQUIBB CO
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
66603002018/03/19U-542PDF格式
64755212018/03/19PDF格式
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
021202016APLetter2008/08/28下载
021202016APLabel2008/08/29下载
021202015APLabel2006/11/06下载
021202015APLetter2006/11/06下载
021202013APLetter2004/03/24下载
021202011APLetter2004/03/24下载
021202008APLabel2003/04/17下载
021202008APLetter2003/04/18下载
021202003APLetter2002/01/08下载
021202001APLetter2001/04/19下载
021202000APLetter2000/10/13下载
021202000APLabel2000/10/13下载
021202000APReview2004/06/04下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
021202020AP2014/03/05Manufacturing Change or Addition
021202019AP2014/01/31Manufacturing Change or Addition
021202016AP2008/08/27Labeling Revision
021202015AP2006/11/01Labeling Revision
021202013AP2004/03/19Labeling Revision
021202011AP2004/03/19Labeling Revision
021202008AP2003/04/11Formulation Revision
021202006AP2002/06/06Expiration Date Change
021202005AP2002/07/02Manufacturing Change or Addition
021202004AP2002/01/08Manufacturing Change or Addition
021202003AP2002/01/08Labeling Revision
021202002AP2001/07/31Manufacturing Change or Addition
021202001AP2001/04/19Labeling Revision
021202000AP2000/10/13Approval